In AD, it was observed that high glucose concentrations in the brain are associated with greater severity in the deposition of amyloid plaque, associated with a decrease in the expression of GLUT3, but not GLUT1 [77]. The gene discussed is SLC2A3; the disease is Alzheimer disease.